Skip to main content
RISE logo

NextBioForm: Centre for formulation and processing of biologics

Biological drugs are excellent therapies, but sensitive and often difficult drug products. It is often hard to create stable formulations, which means that the drug must be kept cooled, which limits the patient's everyday life. NextBioForm aims to build knowledge, methods and capabilities to support development better biological drugs products.

NextBioForm is a centre for competence development, innovation and development of formulations and process technologies for biologically based pharmaceuticals. In this project, RISE works together with partners from both industry and academia with the aim of creating knowledge and methods that are needed to develop medicines that are easier for the patient to use, and thereby improve quality of life.

The goal is to become an internationally leading centre in this area. The centre works on developing technology to be able to measure the stability of various approaches, investigates what triggers destabilisation and develops new formulation platforms. NextBioForm is operated in active collaboration, which offers a platform where several methodologies and techniques can be verified against each other through studies with well-known proteins.


Project name





Region Stockholm

RISE role in project


Project start


6 years


Lund Universitet, Malmö Universitet, MAX IV, Akademiska Sjukhuset i Uppsala, Swedish Orphan Biovitrum AB, BioGaia AB, Regenics AS, Ilya Pharma AB, Spiber Technologies AB, Ferring Pharmaceuticals AB, Vironova AB, Solve Research and Consultancy AB, CR Competence AB, SARomics, ENZA Biotech, Sofus Regulatory Affairs AB, Biogardia AB



Project website


External press

Read more at our project webpage

Supports the UN sustainability goals

3. Good health and well-being
Anna Fureby

Contact person

Anna Fureby


+46 10 516 60 46

Read more about Anna

Contact Anna
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

* Mandatory By submitting the form, RISE will process your personal data.




An aging population means that more people are dealing with chronic diseases. Many illnesses still lack treatment, but we also see new opportunities for treatment, cure and a healthier life through precision medicine, bi…

New therapies

Sweden is still a strong nation when it comes to development and production of pharmaceuticals. Pharmaceuticals constituted Sweden’s second largest export post 2022, adding up to 7% of the total export, with a value of almost 140 …

Formulated products

Medicine, make-up and mayonnaise are formulated products used on a daily basis. A formulated product consists of a minimum of two, but often many more, ingredients selected, processed and combined in a specific manner to provide a…

Biocompatibility evaluation

All medical devices have to undergo a biological evaluation of biocompatibility to fulfill the requirements in the EU Medical Device Regulation (MDR). We can help you with everything from setting up a biological safety evaluation …


What do skin lotions, paints, painkiller pills and mayonnaise have in common? Well, they are all formulated products. As such, their final properties and function are the result of the formulation work, this is, the process of sel…

Sustainable protein

Due to climate and health aspects there is an increasing interest to switch to a more sustainable production and consumption of proteins. RISE wants to contribute to this development, for example, by developing new products f…

Biochemistry and bioanalytical chemistry

We have cutting-edge expertise and years of experience within analytical methods for organic compounds and their metabolites in biological matrices.

Protein functionality

For us to find the best extraction method for each raw material to reach the optimal product, analysis of the physical properties of the protein is required. With biochemical analysis we can investigate the protein at the molecula…